Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 415
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06235697 | Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment | ||
| NCT00354302 | Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial | ||
| NCT00083174 | Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer | ||
| NCT00093457 | Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer | ||
| NCT01144468 | Effects of Exemestane on Bone Strength | ||
| NCT03477591 | Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions | ||
| NCT00260975 | Study of the Effects of Chemotherapy on Memory and Other Mental Functions in Women With Breast Cancer | ||
| NCT00303160 | Effect of Helicobacter Pylori on the Availability of Vitamin E and C | ||
| NCT00003653 | Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer | ||
| NCT03259035 | NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer | ||
| NCT00002678 | Combination Chemotherapy in Treating Patients With Multiple Myeloma | ||
| NCT01815476 | The Prone Breast Radiation Therapy Trial | ||
| NCT05576831 | STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision | ||
| NCT06623461 | LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma | ||
| NCT02743741 | Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors | ||
| NCT02446405 | Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer | ||
| NCT00002570 | Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease | ||
| NCT04918186 | Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer | ||
| NCT04557501 | PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer | ||
| NCT00535353 | AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer | ||
| NCT02414022 | Economic Analysis of Alliance A041202 CLL Study | ||
| NCT05255653 | Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features | ||
| NCT05300711 | Preventing Ovarian Cancer Through Oportunistic Salpingectomy at the Time of Colorectal Surgery | ||
| NCT01652144 | A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed Mantle Cell Lymphoma | ||
| NCT02043236 | Strategies to Improve Bone Health in Men on ADT | ||
| NCT00305812 | Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma | ||
| NCT03568422 | CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer | ||
| NCT03938987 | Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) | ||
| NCT00869752 | MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer | ||
| NCT00036647 | OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT03059199 | HAT TRICK: An Innovative Health Promotion Program for Men | ||
| NCT02927249 | Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy | ||
| NCT02936258 | PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation Procedures | ||
| NCT00170235 | Reducing Arm Morbidity in Pre- and Post-breast Cancer Surgery | ||
| NCT02660788 | A Randomized Trial of Letters From Family Physicians to Encourage Screening Mammography in Overdue Women | ||
| NCT03847649 | A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies | ||
| NCT01780623 | An Investigation of Light Therapy for Cancer-related Fatigue (The LITE Study) | ||
| NCT02773524 | A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer | ||
| NCT02343718 | Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours | ||
| NCT00016380 | Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen | ||
| NCT01184274 | A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia | ||
| NCT04224974 | Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia | ||
| NCT06519682 | A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG) | ||
| NCT01342302 | An Online Psychoeducational Intervention for Young Women With Breast Cancer and Their Partners | ||
| NCT03127631 | A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients | ||
| NCT04031677 | Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma | ||
| NCT05116137 | The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors | ||
| NCT03631758 | Evaluating the Impact of Evidence-based Information About Mammography on Breast Cancer Screening Decisions | ||
| NCT01075308 | SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer | ||
| NCT04161248 | Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma |
